PART I Overview and Mission Myriad Genetics is a leading molecular diagnostics and precision medicine company committed to advancing health and well-being for all. We develop and commercialize molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more ...
Q2 FY2026 — expected 2026-08-12
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | MYGN | discussed_in_filing Artificial Intelligence | |
| topic_mention | MYGN | discussed_in_filing Cybersecurity | |
| topic_mention | MYGN | discussed_in_filing Trusted Computing | |
| topic_mention | MYGN | discussed_in_filing Blockchain & Crypto | |
| topic_mention | MYGN | discussed_in_filing Regulation | |
| topic_mention | MYGN | discussed_in_filing Healthcare & Bio | |
| topic_mention | MYGN | discussed_in_filing Platform & Ecosystem | |
| topic_mention | MYGN | discussed_in_filing Sovereign & Government | |
| topic_mention | MYGN | discussed_in_filing Artificial Intelligence | |
| topic_mention | MYGN | discussed_in_filing Cybersecurity | |
| topic_mention | MYGN | discussed_in_filing Trusted Computing | |
| topic_mention | MYGN | discussed_in_filing Blockchain & Crypto | |
| topic_mention | MYGN | discussed_in_filing Regulation | |
| topic_mention | MYGN | discussed_in_filing Healthcare & Bio | |
| topic_mention | MYGN | discussed_in_filing Platform & Ecosystem | |
| topic_mention | MYGN | discussed_in_filing Sovereign & Government | |
| topic_mention | MYGN | discussed_in_filing Artificial Intelligence | |
| topic_mention | MYGN | discussed_in_filing Cybersecurity | |
| topic_mention | MYGN | discussed_in_filing Trusted Computing | |
| topic_mention | MYGN | discussed_in_filing Blockchain & Crypto |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0000899923-26-000018 | EDGAR | 72K words |
| 2025-02-28 | 2024-12-31 | 0000899923-25-000019 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000899923-24-000018 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0000899923-23-000011 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0000899923-22-000033 | EDGAR | — |
| 2020-08-13 | 2020-06-30 | 0001564590-20-040011 | EDGAR | — |
| 2019-08-13 | 2019-06-30 | 0001564590-19-031849 | EDGAR | — |
| 2018-08-24 | 2018-06-30 | 0001564590-18-022312 | EDGAR | — |
| 2017-08-09 | 2017-06-30 | 0001564590-17-017026 | EDGAR | — |
| 2016-08-10 | 2016-06-30 | 0001193125-16-677859 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0000899923-25-000112 | EDGAR | 20K words |
| 2025-08-06 | 2025-06-30 | 0000899923-25-000086 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000899923-25-000048 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000899923-24-000057 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000899923-24-000041 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000899923-24-000026 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000899923-23-000087 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000899923-23-000058 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000899923-23-000035 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000899923-22-000140 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0000899923-22-000130 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0000899923-22-000079 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-23 | 0000899923-26-000012 | EDGAR | 9K words |
| 2026-01-12 | 0000899923-26-000003 | EDGAR | — |
| 2025-11-03 | 0000899923-25-000103 | EDGAR | — |
| 2025-10-07 | 0000899923-25-000096 | EDGAR | — |
| 2025-10-03 | 0000899923-25-000091 | EDGAR | — |
| 2025-08-18 | 0000899923-25-000089 | EDGAR | — |
| 2025-08-05 | 0000899923-25-000084 | EDGAR | — |
| 2025-07-31 | 0000899923-25-000072 | EDGAR | — |
| 2025-06-05 | 0000899923-25-000066 | EDGAR | — |
| 2025-05-06 | 0000899923-25-000045 | EDGAR | — |
192 total filings indexed. 160 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000899923 |
| Ticker | MYGN |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report